Abstract
The mitogen-activated protein kinase (MAPK) family of kinases connects extracellular stimuli with diverse cellular responses ranging from activation or suppression of gene expression to the regulation of cell mortality, growth, and differentiation. The MAPK family has been studied extensively; however, the role of these kinases in cell growth and cell-cycle control has become increasingly complex. Patterns have begun to emerge from these studies that show the functions of MAPK subfamilies at different stages of the cell cycle. Their patterns of subcellular localization and movement during the cell cycle are subfamily-specific and have raised many questions about possible cell-cycle functions that have yet to be demonstrated. This article will compare and contrast our current understanding of the functions and localization patterns of the MAPK subfamilies (ERK, BMK, p38, and JNK) in cell-cycle control.
Similar content being viewed by others
References
Kyriakis, J. M. and Avruch, J. (2001) Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81, 807–869.
Morrison, D. K., and Davis, R. J. (2003) Regulation of MAP kinase signaling modules by scaffold proteins in mammals. Annu. Rev. Cell Dev. Biol. 19, 91–118.
Cyert, M. S. (2001) Regulation of nuclear localization during signaling. J. Biol. Chem. 276, 20805–20808.
Lenormand, P., Brondello, J.-M., Brunet, A., and Pouyssgeur, J. (1998) Growth factor-induced p42/p44 MAPK nuclear translocation and retention requires both MAPK activation and neosynthesis of nuclear anchoring proteins. J. Cell Biol. 142, 625–626.
Brunet, A., Roux, D., Lenormand, P., Dowd, S., Keyse, S., and Pouyssgeur, J. (1999) Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry. EMBO J. 18, 664–674.
Hilger, R. A., Scheulen, M. E., and Strumberg, D. (2002) The Ras-Raf-MEK-ERK Pathway in the treatment of cancer. Onkologie 25, 511–518.
Adjei, A. A. (2001) Blocking oncogenic ras signaling for cancer therapy. J. Natl. Cancer Inst. 93, 1062–1074.
Hunter, T. and Pines, J. (1994) Cyclins and cancer II: cyclin D and cdk inhibitors come of age. Cell 79, 572–582.
Ussar, S. and Voss, T. (2004) MEK1 and MEK2, different regulators of the G1/S transition. J. Biol. Chem. 279, 43861–43869.
Chuang, C. F., and Ng, S. Y. (1994) Functional divergence of the MAP kinase pathway. ERK1 and ERK2 activate specific transcription factors. FEBS Lett. 346, 229–234.
Roovers, K. and Assoian, R. K. (2000) Integrating the MAP kinase signal into the G1 phase cell cycle machinery. Bioessays 22, 818–826.
Woo, R. A., and Poon, R. Y. (2003) Cyclin-dependent kinases and S phase control in mammalian cells. Cell Cycle 2, 316–324.
Evans, D. R., and Guy, H. I. (2004) Mammalian pyrimidine biosynthesis: fresh insights into an ancient pathway. J. Biol. Chem. 279, 33035–33038.
Deak, M., Clifton, A. D., Lucocq, J., and Alessi, D. R. (1998) Mitogen- and stress- activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK/p38, and may mediate activation of CREB. EMBO J. 17, 4426–4441.
Prigent, C., and Dimitrov, S. (2003) Phosphorylation of serine 10 in histone H3, what for. J. Cell Sci. 116, 3677–3685.
Liu, X., Yan, S., Zhou, T., Terada, Y., and Erikson, R. L. (2004) The MAP kinase pathway is required for entry into mitosis and cell survival. Oncogene 23, 763–776.
Shapiro, P. S., Vaisberg, E., Hunt, A. J., Tolwinski, N. S., Whalen, A. M., McIntosh, J. R., and Ahn, N. G. (1998) Activation of the MKK/ERK pathway during somatic cell mitosis: direct interactions of active ERK with kinetochores and regulation of the mitotic 3F3/2 phosphoantigen. J. Cell Biol. 142, 1533–1545.
Willard, F. S. and Crouch, M. F. (2001) MEK, ERK, and p90RSK are present on mitotic tubulin in Swiss 3T3 cells: a role for the MAP kinase pathway in regulating mitotic exit. Cell Signal. 13, 653–664.
Zecevic, M., Catling, A. D., Eblen, S. T., et al. (1998) Active MAP kinase in mitosis: localization at kinetochores and association with the motor protein CENP-E. J. Cell Biol. 142, 1547–1558.
Gachet, Y., Tournier, S., Millar, J. B., and Hyams, J. S. (2001) A MAP kinase-dependent actin checkpoint ensures proper spindle orientation in fission yeast. Nature 412, 352–355.
Sharp, D. J., Rogers, G. C., and Scholey J. M. (2000) Microtubule motors in mitosis. Nature 407, 41–47.
Kallio, M. J., Beardmore, V. A., Weinstein, J., and Gorbsky, G. J. (2003) Rapid microtubule-independent dynamics of Cdc20 at kinetochores and centrosomes in mammalian cells. J. Cell Biol. 158, 841–847.
Chung, E. and Chen, R. H. (2003) Phosphorylation of Cdc20 is required for its inhibition by the spindle checkpoint. Nat. Cell Biol. 5, 748–753.
Zhou, G., Bao, Z. Q., and Dixon, J. E. (1995) Components of a new human protein kinase signal transduction pathway. J. Biol. Chem. 270, 12665–12669.
Regan, C. P., Li, W., Boucher, D. M., Spatz, S., Su, M. S., and Kuida, K. (2002) Erk5 null mice display multiple extraembryonic vascular and embryonic cardiovascular defects. Proc. Natl. Acad. Sci. USA 99, 9248–9253.
Chao, T. H., Hayashi, M., Tapping, R. I., Kato, Y., and Lee, J. D. (1999) MEKK3 directly regulates MEK5 as part of the big mitogen-activated protein kinase 1 (BMK1) signaling pathway. J. Biol. Chem. 274, 36035–36038.
Abe, J. I., Kusuhara, M., Berk, B. C., and Lee, J. D. (1996) Big mitogen-activated protein kinase 1 (BMK1) is a redoxsensitive kinase. J. Biol. Chem. 271, 16586–16590.
Kato, Y., Kravchenko, V. V., Tapping, R. I., Han, J., Ulevitch, R. J., and Lee, J. D. (1997) BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. EMBO J. 16, 7054–7066.
Yan, C., Luo, H., Lee, J. D., Abe, J., and Berk, B. C. (2001) Molecular cloning of mouse ERK5/BMK1 splice variants and characterization of ERK5 functional domains. J. Biol. Chem. 276, 10870–10878.
Lin, Q., Schwarz, J., Bucana, C., and Olson, E. N. (1997) Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 276, 1404–1407.
English, J. M., Pearson, G., Hockenberry, T., Shivakumar, L., White, M. A., and Cobb, M. H. (1999) Contribution of the ERK5/MEK5 pathway to Ras/Raf signaling and growth control. J. Biol. Chem. 274, 31588–31592.
Kato, Y., Chao, T. H., Hayashi, M., Tapping, R. I., and Lee, J. D. (2000) Role of BMK1 in regulation of growth factor-induced cellular responses. Immunol. Res. 21, 233–237.
Pearson, G., English., J. M., White, M. A., and Cobb, M. H. (2001) ERK5 and ERK2 cooperate to regulate NF-kB and cell transformation. J. Biol. Chem. 276, 7927–7931.
Tapping, R. I., Yutaka, K., Chao, T. H., Hayashi, M., Lo, J. F., Kim, S. W., and Lee, J. D. (2004) Investigating the cellular BMK1/ERK5 signaling pathway. Methods Mol. Biol. 250, 89–96.
Raviv, Z., Kalie, E., and Seger, R. (2004) MEK5 and ERK5 are localized in the nuclei of resting as well as stimulated cells, while MEKK2 translocates from the cytosol to the nucleus upon stimulation. J. Cell Sci. 117, 1773–1784.
Han, J., Lee, J. D., Bibbs, L., and Ulevitch, R. J. (1994) A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265, 808–811.
Jiang, Y., Chen, C., Li, Z., Guo, W., Gegner, J. A., Lin, S., and Han, J. (1996) Characterization of the structure and function of a new mitogen-activated protein kinase (p38b). J. Biol. Chem. 271, 17920–17926.
Jiang, Y., Gram, H., Zhao, M., et al. (1997) Characterization of the structure and function of the fourth member of the p38 group of mitogen-activated protein kinases, p38d. J. Biol. Chem. 272, 30122–30128.
Li, Z., Jiang, Y., Ulevitch, R. J., and Han, J. (1996) The primary structure of p38 gamma: a new member of p38 group of MAP kinases. Biochem. Biophys. Res. Commun. 228, 334–340.
Wang, X. S., Diener, K., Manthey, C. L., et al. (1997) Molecular cloning and characterization of a novel p38 mitogen-activated protein kinase. J. Biol. Chem. 272, 23668–23674.
Raingeaud, J., Gupta, S., Rogers, J. S. et al. (1995) Proinflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 270, 7420–7426.
Read, M. A., Whitley, M. Z., Gupta, S., et al. (1997) Tumor necrosis factor α-induced E-selectin expression is activated by the nuclear factor-kB and c-JUN N-terminal kinase/p38 mitogen-activated protein kinase pathways. J. Biol. Chem. 272, 2753–2761.
Aplin, E. A., Hogan, B. P., Tomeu, J. and Juliano, R. L. (2002) Cell adhesion differentially regulates the nucleocytoplasmic distribution of active MAP kinases. J. Cell Sci. 115, 2781–2790.
Ben-Levy, R., Hooper, S., Wilson, R., Paterson, H. F., and Marshall, C. J. (1998) Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAP-KAP kinase-2. Curr. Biol. 8, 1049–1057.
Mudgett, J. S., Ding, J., Guh-Siesel, L., et al. (2000) Essential role for p38a mitogen-activated protein kinase in placental angiogenesis. Proc. Natl. Acad. Sci. U S A 97, 10454–10459.
Allen, M., Svensson, L., Roach, M., Hambor, J., McNeish, J., and Gabel, C. A. (2000) Deficiency of the stress kinase p38α results in embryonic lethality: characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells. J. Exp. Med. 191, 859–869.
Campos, C. B., Bedard, P. A., and Linden, R. (2002) Activation of p38 mitogen-activated protein kinase during normal mitosis in the developing retina. Neuroscience 112, 583–591.
Molnar, A., Theodoras, A. M., Zon, L. I., and Kyriakis, J. M. (1997) Cdc42Hs, but not Rac1, inhibits serum-stimulated cell cycle progression at G1/S through a mechanism requiring p38/RK. J. Biol. Chem. 272, 13229–13235.
Swenson, K. I., Winkler, K. E., and Means, A. R. (2003) A new identity for MLK3 as a NIMA-related, cell cycle-regulated kinase that is localized near centrosomes and influences microtubule organization. Mol. Cell. Biol. 14, 156–172.
Kishi, H., Nakagawa, K., Matsumoto, M., et al. (2001) Osmotic shock induces G1 arrest through p53 phosphorylation at Ser33 by activated p38MAPK without phosphorylation at Ser15 and Ser20. J. Biol. Chem. 276, 39115–39122.
Kim, G. Y., Mercer, S. E., Ewton, D. Z., Yan, Z., Jin, K., and Friedman, E. (2002) The, stress-activated protein kinases p38 alpha and JNK1 stabilize p21(Cip1) by phosphorylation. J. Biol. Chem. 277, 29792–29802.
Xiu, M., Kim, J., Sampson, E., Huang, C. Y., Davis, R. J., Paulson, K. E., and Yee, A. S. (2003) The transcriptional repressor HBP1 is a target of the p38 mitogen-activated protein kinase pathway in cell cycle regulation. Mol. Cell Biol. 23, 8890–8901.
Casanovas, O., Miro, F., Estanol, J. M., Itarte, E., Agell, N., and Bachs, O. (2000) Osmotic stress regulates the stability of cyclin D1 in a p38SAPK2-dependent manner. J. Biol. Chem. 275, 35091–35097.
Lavoie, J. N., L’Allemain, G., Brunet, A., Muller, R., and Poussegur, J. (1996) Cyclin D1 expression is regulated positively by the p42/p44 MAPK and negatively by the p38/HOG MAPK pathway. J. Biol. Chem. 271, 20608–20618.
Yee, A. S., Paulson, E. K., McDevitt, M. A. et al. (2004) The HBP1 transcriptional repressor and the p38 MAP kinase: unlikely partners in G1 regulation and tumor suppression. Gene 336, 1–13.
Nath, N., Wang, S., Betts, V., Knudsen, E., and Chellappan, S. (2003) Apoptotic and mitogenic stimuli inactivate Rb by differential utilization of p38 and cyclin-dependent kinases. Oncogene 22, 5986–5894.
Bulavin, D. V., Higashimoto, Y., Popoff, I. J., et al. (2001) Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase. Nature 401, 102–107.
Takenaka, K., Moriguchi, T., and Nishida, E. (1998) Activation of the protein kinase p38 in the spindle assembly checkpoint and mitotic arrest. Science. 280, 599–602.
Wang, X., McGowan, C. H., Zhao, M., et al. (2000) Involvement of the MKK6-p38γ cascade in g-radiation-induced cell cycle arrest. Mol. Cell. Biol. 20, 4543–4552.
Gupta, S. Barrett, T., Whitmarsh, A. J., (1996) Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J. 15, 2760–2770.
Mohit, A. A., Martin, J. H., and Miller, C. A. (1995) p493F12 kinase: a novel MAP kinase expressed in a subset of neurons in the human nervous system. Neuron 14, 67–78.
Derijard, B., Hibi, M., Wu, I. H. et al. (1994) JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76, 1025–1037.
Kyriakis, J. M., Banerjee, P., Nikolakaki, E., et al. (1994) The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369, 156–160.
Dickens, M., Rogers, J. S., Cavanaugh, J., et al. (1997) A cytoplasmic inhibitor of the JNK signal transduction pathway. Science 277, 693–696.
MacCorkle-Chosnek, R. A., VanHooser, A., Goodrich, D. W., Brinkley, B. R., and Tan, T. H. (2001) Cell cycle regulation of c-Jun N-terminal kinase activity at the centrosomes. Biochem. Biophys. Res. Commun. 289, 173–180.
Kharbanda, S., Saxena, S., Yoshida, K., et al. (2000) Translocation of SAPK/JNK to mitochondria and interaction with Bcl-XL in response to DNA damage. J. Biol. Chem. 275, 322–332.
Eminel, S., Klettner, A., Roemer, L., Herdegen, T., and Waetzig, V. (2004) JNK2 translocates to the mitochondria and mediates cytochrome c release in PC12 cells in response to 6-hydroxydopamine. J. Biol. Chem. 279, 55385–55392.
Mizukami, Y., Yoshioka, K., Morimoto, S., and Yoshida, K. (1997) A novel mechanism of JNK1 activation. Nuclear translocation and activation of JNK1 during ischemia and reperfusion. J. Biol. Chem. 272, 16657–16662.
Dong, C., Yang, D. D., Wysk, M., Whitmarsh, A. J., Davis, R. J., and Flavell, R. A. (1998) Defective T-cell differentiation in the absence of Jnk1. Science 282, 2092–2095.
Kuan, C. Y., Yang, D. D., Samantha, R. D. R., Davis, R. J., Rakic, P., and Flavell, R. A. (1999) The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron 22, 667–676.
Yamamoto, K., Ichijo, H., and Korsemeyer, S. J. (1999) BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G2/M. Mol. Cell. Biol. 19, 8469–8478.
Yang, D. D., Kuan, C. Y., Whitmarsh, A. J., et al. (1997) Absence of excitoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389, 865–870.
Yang, D. D., Conze, D., Whitmarsh, A. J., et al. (1998) Differentiation of CD4+ T-cells to Th1 cells requires MAP kinase JNK2. Immunity 9, 575–585.
Sabapathy, K., Jochum, W., Hochedlinger, K., Chang, L., Karin, M. and Wagner, E. F. (1999) Defective neural tube closure and altered apoptosis in the absence of both JNK1 and JNK2. Mech. Dev. 89, 115–124.
Sabapathy, K., Hu, Y., Kallunki, T., et al. (1999) JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development. Curr. Biol. 9, 116–125.
Patel, R., Bartosch, B., and Blank, J. L. (1998) p21WAF1 is dynamically associated with JNK in human T-lymphocytes during cell cycle progression. J. Cell. Sci. 111, 2247–2255.
Shim, J., Lee, H., Park, J., Kim, H., and Choi, E. J. (1996) A non-enzymatic p21 protein inhibitor of stress-activated protein kinases. Nature 381, 804–807.
Potapova, O., Gorospe, M., Bost, F., et al. (2000) c-Jun N-terminal kinase is essential for growth of human T98G glioblastoma cells. J. Biol. Chem. 275, 24767–24775.
MacCorkle, R. A. and Tan, T.-H. (2004) Inhibition of JNK2 disrupts anaphase and produces aneuploidy in mammalian cells. J. Biol. Chem. 279, 40112–40121.
Du, L., Lyle, C. S., Obey, T. B., et al. (2004) Inhibition of cell proliferation and cell cycle progression by specific inhibition of basal JNK activity: evidence that mitotic bxl-2 phosphorylation is JNK-independent. J. Biol. Chem. 279, 11957–11966.
Fan, M., Du, L., Stone, A. A., Gilbert, K. M., and Chambers, T. C. (2000) Modulation of mitogen-activated protein kinases and phosphorylation of Bcl-2 by vinblastine represent persistent forms of normal fluctuations at G2-M1. Cancer Res. 60, 6403–6407.
Mingo-Sion, A. M., Marietta, P. M., Koller, E., Wolf, D. M., and Van Den Berg, C. L. (2004) Inhibition of JNK reduces G2/M transit independent of p53, leading to endoreduplication, decreased proliferation, and apoptosis in breast cancer cells. Oncogene 23, 596–604.
Bennett, B. L., Sasaki, D. T., Murray, B. W., et al. (2001) SP600125, an anthrapyrazole inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA 98, 13681–13686.
Yu, J., Liu, X. W., and Kim, H. R. (2003) Platelet-derived growth factor (PDGF) receptor-alpha-activated c-Jun NH2-terminal kinase-1 is critical for PDGF-induced p21WAF1/CIP1 promoter activity independent of p53. J. Biol. Chem. 278, 49582–49588.
Buschmann, T., Potapova, O., Bar-Shira, A., et al. (2001) Jun NH2-terminal kinase phosphorylation of p53 on Thr-81 is important for p53 stabilization and transcriptional activities in response to stress. Mol. Cell. Biol. 21, 2743–2754.
Tchou, W. W., Yie, T. A., Tan, T.-H., Rom, W. N., and Tchou-Wong, K. M. (1999) Role of c-Jun N-terminal kinase 1 (JNK1) in cell cycle checkpoint activated by the protease inhibitor N-acetyl-leucinyl-leucinyl-norleucinal. Oncogene 18, 6974–6980.
Sabapathy, K., Kallunki, T., David, J. P., Graef, I., Karin, M., and Wagner, E. F. (2001) c-Jun NH2-terminal kinase (JNK)1 and JNK2 have similar and stage-dependent roles in regulating T-cell apoptosis and proliferation. J. Exp. Med. 193, 317–328.
Hochedlinger, K., Wagner, E. F., and Sabapathy, L. (2002) Differential effects of JNK1 and JNK2 on signal specific induction of apoptosis. Oncogene 21, 2441–2445.
Yang, Y. M., Bost, F., Charbono, W., et al. (2003) C-Jun NH2-terminal kinase mediates proliferation and tumor growth of human prostate carcinoma. Clin. Cancer Res. 9, 391–401.
Tsuiki, H., Tnani, M., Okamoto, I., et al. (2003) Constitutively active forms of c-Jun NH2-terminal kinase are expressed in primary glial tumors. Cancer Res. 63, 250–255.
Biggs, W. H. and Zipursky, S. L. (1992) Primary structure, expression, and signal-dependent tyrosine phosphorylation of a Drosophila homolog of extracellular signal-regulated kinase. Proc. Natl. Acad. Sci. USA 89, 6295–6299.
Lackner, M. R., Kornfeld, K., Miller, L. M., Horvitz, H. R., and Kim, S. K. (1994) A MAP kinase homolog, mpk-1, is involved in ras-mediated induction of vulval cell fates in Cacnorhabditis elegans. Genes. Dev. 8, 160–173.
Courchesne, W. E., Kunisawa, R., and Thorner, J. (1989) A putative protein kinase overcomes pheromone-induced arrest of cell cycling in S. cerevisiae. Cell 58, 1107–1119.
Han, S. J., Choi, K. Y., Brey, P. T., Lee, W. J. (1998) Molecular cloning and characterization of a Drosophila p38 mitogen-activated protein kinase. J. Biol. Chem. 273, 369–374.
Berman, K., McKay, J., Avery, L., and Cobb, M. (2001) Isolation and characterization of pmk-(1–3): three p38 homologs in Caenorhabditis elegans. Mol. Cell. Biol. Res. Commun. 4, 337–344.
Brewster, J. L., de Valoir, T., Dwyer, N. D., Winter, E. and Gustin, M. C. (1993) An osmosensing signal transduction pathway in yeast. Science 259, 1760–1763.
Sluss, H. K., Han, Z., Barrett, T., Davis, R. J., and Ip, Y. T. (1996) A JNK signal transduction pathway that mediates morphogenesis and an immune response in Drosophila. Genes Dev. 10, 2745–2758.
Kawasaki, M., Hisamoto, N., Iono, Y., Yamamoto, M., Ninomiya-Tsuji, J., and Matsumoto, K. A. (1999) Caenorhabditis elegans JNK signal transduction pathway regulates coordinated movement via type-D GABAergic motor neurons. EMBO J. 18, 3604–3615.
Pages, G., Guerin, S., Grall, D., et al. (1999) Defective thymocyte maturation in p44 MAP kinase (Erk1) knockout mice. Science 286, 1374–1377.
Mazzucchelli, C., Vantaggiato, C., Ciamei, A et al. (2002) Knockout of ERK1 MAP kinase enhances synaptic plasticity in the striatum and facilitates striatal-mediated learning and memory. Neuron 34, 807–820.
Saba-El-Leil, M. K., Vella, F. D., Vernay, B., et al. (2003) An essential function of the mitogen-activated protein kinase Erk2 in mouse trophoblast development. EMBO Rep. 10, 964–968.
Constant, S. L., Dong, C., Yang, D. D., Wysk, M., Davis, R. J., and Flavell, R. A. (2000) JNK1 is required for T-cell-mediated immunity against Leishmania major infection. J. Immunol. 165, 2671–2676.
She, Q. B., Chen, N., Bode, A. M., Flavell, R. A., and Dong, Z. (2002) Deficiency of c-Jun-NH2-terminal kinase-1 in mice enhances skin tumor development by 12-O-tertradecanoylphorbol-13-acetate. Cancer Res. 62, 1343–1348.
Chen, N., Nomura, M., She, Q. B., et al. (2001) Suppression of skin tumourigensis in c-Jun NH2-terminal kinase-2-deficient mice. Cancer Res. 61, 3908–1912.
Tournier, C., Hess, P., Yang, D. D., et al. (2000) Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288, 870–874.
Adams, R. H., Porras, A., Alonso, G., et al. (2000) Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development. Mol. Cell. 6, 109–116.
Tamura, K., Sudo, T., Senftleben, U., Dadak, A. M., Johnson, R., and Karin, M. (2000) Requirement for p38a in erythropoietin expression: a role for stress kinases in erythropoiesis. Cell 102, 221–231.
Mudgett, J. S., Ding, J., Guh-Siesel, L., et al. (2000) Essential role for p38alpha mitogen-activated protein kinase in placental angiogenesis. Proc. Natl. Acad. Sci. USA 97, 10454–10459.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
MacCorkle, R.A., Tan, TH. Mitogen-activated protein kinases in cell-cycle control. Cell Biochem Biophys 43, 451–461 (2005). https://doi.org/10.1385/CBB:43:3:451
Issue Date:
DOI: https://doi.org/10.1385/CBB:43:3:451